| Drug Name |
Valganciclovir |
| Drug ID |
BADD_D02326 |
| Description |
Valganciclovir hydrochloride (Valcyte, manufactured by Roche) is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases. |
| Indications and Usage |
Valganciclovir is an antiviral medication used for the treatment of cytomegalovirus infections. |
| Marketing Status |
approved; investigational |
| ATC Code |
J05AB14 |
| DrugBank ID |
DB01610
|
| KEGG ID |
D02495
|
| MeSH ID |
D000077562
|
| PubChem ID |
135413535
|
| TTD Drug ID |
D06GWF
|
| NDC Product Code |
69097-277; 31722-832; 50268-787; 60429-846; 70069-810; 71921-210; 27241-158; 55111-762; 61269-480; 0004-0038; 70010-051; 0904-6796; 63739-076; 68084-965; 71151-003 |
| UNII |
GCU97FKN3R
|
| Synonyms |
Valganciclovir | Ganciclovir L-valyl Ester | Ganciclovir L valyl Ester | Valcyt | Valganciclovir Hydrochloride | Valcyte |
